Indexing hint: Clinical trial · 2017
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.
Karpova et al. 2017Journal of translational medicinecited by 42
PMID 28049490PMC5209880DOI 10.1186/s12967-016-1107-2PUB-28049490